Roche's Cobas CMV Viral Load Assay Gets CE Mark | GenomeWeb

NEW YORK (GenomeWeb) – Roche today announced that its Cobas CMV viral load assay for human cytomegalovirus has received CE marking.

The real-time PCR-based assay, which runs on the Cobas 6800/8800 systems, meets the first World Health Organization International Standard for Human Cytomegalovirus for Nucleic Acid Amplification Techniques and, therefore, provides consistent and reliable results for monitoring the viral load in transplant patients receiving an anti-viral therapy, Roche said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.